Myocardial ischemia-reperfusion injury is enhanced in a model of systemic allergy and asthma

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 5 55-5, 2004, Pages

  Hazarika, Surovi ^a   Van Scott, Michael R ^a   Lust, Robert M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Inflammation; Neutrophils

Indexed keywords

ADJUVANT; ALLERGEN; TRIPHENYLTETRAZOLIUM;

AIRWAY; ALLERGY; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL COUNT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE EXACERBATION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; INJECTION; MODEL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; SENSITIZATION; STAINING;

ANIMALS; ASTHMA; BLOOD CELL COUNT; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LEUKOCYTE COUNT; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHILS; PYROGLYPHIDAE; RABBITS; SEVERITY OF ILLNESS INDEX;

EID: 1942501655     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01064.2003     Document Type: Article

References (37)

1. 1 receptor. J Pharmacol Exp Ther 268: 1328-1334, 1994.
2. Bao D, Wiehler S, and Patel KD. Increased PSGL-1 expression on granulocytes from allergic-asthmatic subjects in enhanced leukocyte recruitment under flow conditions. J Leukoc Biol 72: 702-710, 2002.
3. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AM, Schwartz LB, Durham SR, Jeffery PK, and Kay AB. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 88: 661, 1991.
4. 2 induce IL-18 and IL-18 Rb expression in cardiomyocytes via NF-κB activation. Biochem Biophys Res Commun 303: 1152-1158, 2003.
5. Coughlin SS, Metayer C, McCarthy EP, Mather FJ, Waldhorn RE, Gersh BJ, DuPraw S, and Baughman KL. Respiratory illness, β-agonists, and risk of idiopathic dilated cardiomyopathy. The Washington, DC, Dilated Cardiomyopathy Study. Am J Epidemiol 142: 395-403, 1995.
6. Coughlin SS, Szklo M, Baughman K, and Pearson TA. Idiopathic dilated cardiomyopathy and atopic disease: epidemiologic evidence for an association with asthma. Am Heart J 118: 768-774, 1989.
7. Coughlin SS and Tefft MC. The epidemiology of idiopathic dilated cardiomyopathy in women: the Washington, DC, Dilated Cardiomyopathy Study. Epidemiology 5: 449-455, 1994.
8. Dai S. Histamine enhances hypoxia-induced ventricular arrhythmias in isolated rat hearts. Clin Exp Pharmacol Physiol 16: 925-931, 1989.
9. Drislane FW, Samuels MA, Kozakewich H, Schoen FJ, and Strunk RC. Myocardial contraction band lesions in patients with fatal asthma: possible neurocardiologic mechanisms. Am Rev Respir Dis 135: 498-501, 1987.
10. Frangogiannis NG, Smith CW, and Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002.
11. Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, Michael LH, Ballantyne CM, Smith CW, and Entman ML. Cytokines and the microcirculation in ischemia and reperfusion. Mol Cell Cardiol 30: 2567-2576, 1998.
12. Gibson PG, Simpson JL, and Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119: 1329-1336, 2001.
13. James EJ, Zhao ZQ, and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43: 860-878, 1999.
14. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, and Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160: 1532-1539, 1999.
15. Jazayeri MR, Reen BM, and Edwards JA. Asthma induced myocardial infarction in a patient with normal coronary arteries: a case report and a pathogenetic hypothesis. J Med 13: 351-361, 1983.
16. Jousilahti PSV, Hakala K, Rasi V, Vahtera E, and Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 89: 346-347, 2002.
17. Karol AK, Bonda TA, Korecki J, and Wlodzimierz JM. Oxidative stress and neutrophil activation-the two keystones of ischemia-reperfusion injury. Int J Cardiol 86: 41-59, 2002.
18. Ken S, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, and Yacoub MH. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 104: 308-I-313, 2001.
19. Kips JC. Cytokines in asthma. Eur Respir J Suppl 34: 24s-33s, 2001.
20. Koh YY, Dupuid R, Pollice M, Albertine KH, Fish JE, and Peters SP. Neutrophils recruited to the lungs of humans by segmental allergen challenge display a reduced chemotactic response to leukotriene B4. Am J Respir Cell Mol Biol 8: 493, 1993.
21. Levi RMJ, Bowman FO, and Rosen MR. The arrhythmogenic actions of histamine on human atrial fibers. Circ Res 49: 545-550, 1981.
22. Levine GN, Powell C, Bernard SA, Sherman D, Faling LJ, and Davidoff R. Acute, reversible left ventricular dysfunction in status asthmaticus. Chest 107: 1469-1473, 1995.
23. Levy JH and Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75: S715-S720, 2003.
24. Popper HH, Pailer S, Wurzinger G, Feldner H, Hesse C, and Eber E. Expression of adhesion molecules in allergic lung diseases. Virchows Arch 440: 172-180, 2002.
25. Raper R, Fisher M, and Bihari D. Profound, reversible, myocardial depression in acute asthma treated with high dose catecholamines. Crit Care Med 20: 710-712, 1992.
26. Rhatigan RM and De la Torre A. Myocardial necrosis and bronchial asthma. Ann Allergy 28: 434-438, 1970.
27. Roberto A and Prado EA. Ischemia/reperfusion injury. J Surg Res 105: 248-258, 2002.
28. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 38: 881-885, 2001.
29. --forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochem Biophys Acta 853: 65-89, 1986.
30. Rossinen J, Partanen J, Stenius-Aarniala B, and Nieminen MS. Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease. J Intern Med 243: 361-366, 1998.
31. Seghaye MC, Duchateau J, Grabitz R, Mertes J, Marcus C, Buro K, Messmer B, and von Bernuth G. Histamine liberation related to cardiopulmonary bypass in children: possible relation to transient postoperative arrhythmias. J Thorac Cardiovasc Surg 111: 971-981, 1996.
32. Sengstock DM, Obeidat O, Pasnoori V, Mehra P, Sandberg KR, and McCullough PA. Asthma, β-agonists, and development of congestive heart failure: results of the ABCHF study. J Card Fail 8: 232-238, 2002.
33. Sessler CNCM. Cardiac arrhythmias during theophylline toxicity. A prospective continuous electrocardiographic study. Chest 98: 672-678, 1990.
34. Seesler CN. Theophylline toxicity: clinical features of 116 consecutive cases. Am J Med 88: 567-576, 1990.
35. Simon RJ and Maxwell GYHL. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 58: 95-117, 1997.
36. Welbourn C, Goldman G, Paterson IS, Valeri CR, Shepro D, and Hetchman HB. Pathophysiology of ischemia-reperfusion injury: central role of neutrophil. Br J Surg 78: 651-665, 1991.
37. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, and Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160: 1001-1008, 1999.